- ICH GCP
- Registr klinických studií v USA
- Klinická studie NCT03392012
Effect of Sedation on Pulmonary Aeration in Children (LunSed)
Pediatric sedation is an anesthesiological technique with a good safety profile, but various complications might ensure, especially from the respiratory point of view. No suggestion is available about a possible upper safety limit for the duration of sedation to limit respiratory issue. In order to address this topic, the investigators concentrated on the occurrence of hypoventilated lung areas, which is a well-known side effect of anesthesia and sedation. The investigators hypothesis that the length of sedation is correlated with the occurrence of lung atelectasis and hypoventilation. To assess lung hypoventilation the lung ultrasound will be used. Lung ultrasound will be performed immediately after the induction of sedation and immediately before sedation interruption, in children scheduled for magnetic resonance exams.
The study is a prospective observational study
Přehled studie
Postavení
Podmínky
Detailní popis
Worldwide, an increasing number of medical procedures are performer in children under sedation in many different clinical settings, in compromised patients, often outside the operating theater and often by non-anesthesiologists.
Although a good safety profile accounts for the spread of sedation, various complications might ensure. Furthermore of all the patients receiving sedation for diagnostic and therapeutic procedures, the pediatric population is the subgroup at the highest risk level and with the lowest tolerance of error.
In the last years the results of two large database studies have been published to lend some clarity on the rate and nature of adverse events involving sedation/anesthesia outside the operating room. Respiratory complications were the most frequently reported, and required critical anesthesiological competencies for a correct management to avoid poor outcomes.
Risk factors for adverse events during sedation/anesthesia have been evaluated by the 2016 SIAARTI(Società Italiana di Anestesia, Analgesia, Rianimazione e Terapia Intensiva)-SARNePI (Società di Anestesia e Rianimazione Neonatale e Pediatrica Italiana) guidelines for the standard of pediatric anesthesia, including patients' age, ASA (American Society of Anesthesiology) class, experience of the operators, and urgency/emergency conditions.
On the other hand, no suggestion is available either in current literature or guidelines, about a possible upper safety limit for the duration of sedation. In order to address this topic, the investigators concentrated on the occurrence of hypoventilated lung areas, which is a well-known side effect of anesthesia and sedation. To assess lung hypoventilation the LUSS-Lung Ultrasound Score will be used, since it is a validated and non invasive tool.
The study aims to assess the incidence of atelectasis and hypoventilated lung areas after sedation in children and evaluating possible risk factors for them. The investigators hypothesis that the length of sedation is correlated with the occurrence of lung atelectasis and hypoventilation.
This prospective observational cohort study study could suggest an upper safety limit for the duration of pediatric sedations, which is not reported in the available literature.
Consecutive children (age 1-8 yrs old) scheduled to undergo cerebral or medullary magnetic resonance imaging under deep sedation will be enrolled. In the investigators' center such MR imaging data acquisition (and the relevant sedation) ranges usually between 40 and 120 minutes. Enrollment will take place on the day of sedation.
Informed consent will be obtained from both parents at the preoperative visit or the day of the procedure.
The children will be sedated with propofol iv according to a standard clinical protocol and spontaneous breathing will be maintained throughout the study. The standard protocol has been internally validated both in the clinical and scientific setting.
Immediately after the induction of sedation, lung ultrasound will be performed and the imaging will be scored according to the lung ultrasound score(LUSS). Thereafter the child will be transferred into the magnetic resonance (MR) suite and the MR exam will be performed as required. After completion of MR imaging child will be transferred back to the recovery room and the sonographer will re- assess the LUSS before the discontinuation of sedation. Hence, two lung ultrasound evaluations will be performed: one at the beginning and one at the end of sedation.
Typ studie
Zápis (Očekávaný)
Kontakty a umístění
Studijní místa
-
-
MI
-
Milano, MI, Itálie, 20132
- Nábor
- S. Raffaele Hospital
-
-
Kritéria účasti
Kritéria způsobilosti
Věk způsobilý ke studiu
Přijímá zdravé dobrovolníky
Pohlaví způsobilá ke studiu
Metoda odběru vzorků
Studijní populace
Popis
Inclusion Criteria:
- Children 1-8 years old (included)
- Informed consent of both parents
- Scheduled for elective cerebral or medullary Magnetic Resonance exam
Exclusion Criteria:
- Any ongoing respiratory disease
- Contraindications to the use of propofol
- LUSS ≤12 at the first US assessment (a baseline maximum score 1 on all of the pulmonary fields)
- need for mechanical ventilation
Studijní plán
Jak je studie koncipována?
Detaily designu
Co je měření studie?
Primární výstupní opatření
Měření výsledku |
Popis opatření |
Časové okno |
|---|---|---|
|
Changes in the Lung Ultrasound Score in children undergoing deep sedation
Časové okno: through study completion, an average of 1 hour
|
Lung ultrasound score
|
through study completion, an average of 1 hour
|
Sekundární výstupní opatření
Měření výsledku |
Popis opatření |
Časové okno |
|---|---|---|
|
Effect of sedation length on hypoventilation in children undergoing deep sedation
Časové okno: through study completion, an average of 1 hour
|
Sedation length (min)
|
through study completion, an average of 1 hour
|
|
Incidence of any respiratory and non-respiratory adverse event in children undergoing deep sedation
Časové okno: through study completion, an average of 1 hour
|
Clinical observation
|
through study completion, an average of 1 hour
|
Spolupracovníci a vyšetřovatelé
Sponzor
Vyšetřovatelé
- Studijní židle: Marco Gemma, MD, IRCCS San Raffaele, Milan, Italy
Termíny studijních záznamů
Hlavní termíny studia
Začátek studia (Aktuální)
Primární dokončení (Očekávaný)
Dokončení studie (Očekávaný)
Termíny zápisu do studia
První předloženo
První předloženo, které splnilo kritéria kontroly kvality
První zveřejněno (Aktuální)
Aktualizace studijních záznamů
Poslední zveřejněná aktualizace (Aktuální)
Odeslaná poslední aktualizace, která splnila kritéria kontroly kvality
Naposledy ověřeno
Více informací
Termíny související s touto studií
Klíčová slova
Další identifikační čísla studie
- 140/INT/2017
Plán pro data jednotlivých účastníků (IPD)
Plánujete sdílet data jednotlivých účastníků (IPD)?
Informace o lécích a zařízeních, studijní dokumenty
Studuje lékový produkt regulovaný americkým FDA
Studuje produkt zařízení regulovaný americkým úřadem FDA
Tyto informace byly beze změn načteny přímo z webu clinicaltrials.gov. Máte-li jakékoli požadavky na změnu, odstranění nebo aktualizaci podrobností studie, kontaktujte prosím register@clinicaltrials.gov. Jakmile bude změna implementována na clinicaltrials.gov, bude automaticky aktualizována i na našem webu .
Klinické studie na Sedativní nežádoucí reakce
-
SMG-SNU Boramae Medical CenterNeznámý
-
Orphan MedicalJohns Hopkins UniversityDokončeno
-
Sharon WalshNational Institute on Drug Abuse (NIDA)Dokončeno
-
Janssen Research & Development, LLCDokončenoZdraví nezávislí, rekreační uživatelé sedativ | Potenciál zneužitíSpojené státy
-
LiteVax BVZatím nenabíráme
-
PharmaJet, Inc.National Cancer Institute (NCI); National Institutes of Health (NIH)Staženo
-
IRCCS San Camillo, Venezia, ItalyDokončenoVaccine ReactionItálie
-
Lahore General HospitalAktivní, ne náborPosilovací účinek mRNA vakcíny na protilátkovou odpověď na SARS-CoV-2 po kompletní vakcinaci sinosemVaccine ReactionPákistán
-
PT Bio FarmaCenter for Child Health Universitas Gadjah Mada (CCH-PRO UGM; Cipto Mangunkusumo... a další spolupracovníciDokončenoNežádoucí reakce vakcíny | Vaccine ReactionIndonésie
-
Astellas Pharma IncAstellas Pharma Taiwan, Inc.DokončenoTransplantace jater | Transplantační imunologie | Host vs Graft ReactionTchaj-wan